Search Results

There are 2057 results for: content related to: Paraoxonase 1: Structure, Function, and Polymorphisms

  1. Analysis of paraoxonase 1 (PON1) genetic polymorphisms and activities as risk factors for ischemic stroke in Turkish population

    Cell Biochemistry and Function

    Volume 27, Issue 8, December 2009, Pages: 558–567, Birsen Can Demirdöğen, Şeref Demirkaya, Aysun Türkanoğlu, Semai Bek, Emel Arınç and Orhan Adalı

    Version of Record online : 9 NOV 2009, DOI: 10.1002/cbf.1607

  2. Distribution of paraoxonase-1 gene polymorphisms and enzyme activity in a Peruvian population

    Environmental and Molecular Mutagenesis

    Volume 47, Issue 9, December 2006, Pages: 699–706, Héctor C. Cataño, Jayme L. Cueva, Anthony M. Cardenas, VÍctor Izaguirre, Amparo I. Zavaleta, Elizabeth Carranza and Antonio F. Hernández

    Version of Record online : 31 OCT 2006, DOI: 10.1002/em.20259

  3. You have free access to this content
    Characterization of human paraoxonase 1 variants suggest that His residues at 115 and 134 positions are not always needed for the lactonase/arylesterase activities of the enzyme

    Protein Science

    Volume 22, Issue 12, December 2013, Pages: 1799–1807, Priyanka Bajaj, Rajan K. Tripathy, Geetika Aggarwal and Abhay H. Pande

    Version of Record online : 26 OCT 2013, DOI: 10.1002/pro.2380

  4. You have free access to this content
    The effect of statin therapy on plasma high-density lipoprotein cholesterol levels is modified by paraoxonase-1 in patients with familial hypercholesterolaemia

    Journal of Internal Medicine

    Volume 258, Issue 5, November 2005, Pages: 442–449, T. M. VAN HIMBERGEN, L. J. H. VAN TITS, H. A. M. VOORBIJ, J. DE GRAAF, A. F. H. STALENHOEF and M. ROEST

    Version of Record online : 22 SEP 2005, DOI: 10.1111/j.1365-2796.2005.01557.x

  5. Biologic Activities

    High-Density Lipoproteins: Structure, Metabolism, Function, and Therapeutics

    Anatol Kontush, M. John Chapman, Pages: 192–303, 2011

    Published Online : 28 NOV 2011, DOI: 10.1002/9781118158678.ch7

  6. You have free access to this content
    Inherited and acquired interactions between ACHE and PON1 polymorphisms modulate plasma acetylcholinesterase and paraoxonase activities

    Journal of Neurochemistry

    Volume 92, Issue 5, March 2005, Pages: 1216–1227, Boris Bryk, Liat BenMoyal-Segal, Erez Podoly, Oded Livnah, Arik Eisenkraft, Shai Luria, Amir Cohen, Yoav Yehezkelli, Ariel Hourvitz and Hermona Soreq

    Version of Record online : 4 FEB 2005, DOI: 10.1111/j.1471-4159.2004.02959.x

  7. Paraoxonase activity in two healthy populations with differing rates of coronary heart disease

    European Journal of Clinical Investigation

    Volume 30, Issue 1, January 2000, Pages: 4–10, Mackness, Mackness, Durrington, Arrol, Evans, McMaster, Ferrières, Ruidavets, Williams and Howard

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2362.2000.00580.x

  8. PON gene polymorphisms and ischaemic stroke: a systematic review and meta analysis

    International Journal of Stroke

    Volume 8, Issue 2, February 2013, Pages: 111–123, Hua Liu, Ping Xia, Ming Liu, Xun Ming Ji, Hong Bin Sun, Li Tao and Qi Wen Mu

    Version of Record online : 28 MAY 2012, DOI: 10.1111/j.1747-4949.2012.00813.x

  9. You have full text access to this Open Access content
    Paraoxonase 1 activities and polymorphisms in autism spectrum disorders

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 3, March 2010, Pages: 600–607, Sergiu P. Paşca, Eleonora Dronca, Bogdan Nemeş, Tamás Kaucsár, Emõke Endreffy, Felicia Iftene, Ileana Benga, Rodica Cornean and Maria Dronca

    Version of Record online : 10 JUL 2008, DOI: 10.1111/j.1582-4934.2008.00414.x

  10. Paraoxonases role in the prevention of cardiovascular diseases

    BioFactors

    Volume 35, Issue 1, January/February 2009, Pages: 98–104, Mira Rosenblat and Michael Aviram

    Version of Record online : 18 FEB 2009, DOI: 10.1002/biof.16

  11. Effects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children

    Environmental and Molecular Mutagenesis

    Volume 52, Issue 2, March 2011, Pages: 105–116, Karen Huen, Lisa Barcellos, Kenneth Beckman, Sherri Rose, Brenda Eskenazi and Nina Holland

    Version of Record online : 26 MAR 2010, DOI: 10.1002/em.20567

  12. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients

    Diabetic Medicine

    Volume 21, Issue 5, May 2004, Pages: 423–427, M. Boemi, C. Sirolla, R. Testa, S. Cenerelli, P. Fumelli and R. W. James

    Version of Record online : 5 MAR 2004, DOI: 10.1111/j.1464-5491.2004.01163.x

  13. You have full text access to this OnlineOpen article
    Glycation of paraoxonase-1 inhibits its activity and impairs the ability of high-density lipoprotein to metabolize membrane lipid hydroperoxides

    Diabetic Medicine

    Volume 25, Issue 9, September 2008, Pages: 1049–1055, M. Mastorikou, B. Mackness, Y. Liu and M. Mackness

    Version of Record online : 29 AUG 2008, DOI: 10.1111/j.1464-5491.2008.02546.x

  14. The role of paraoxonase polymorphisms in the induction of micronucleus in paraoxon-treated human lymphocytes

    Environmental and Molecular Mutagenesis

    Volume 50, Issue 9, December 2009, Pages: 823–829, Aurora E. Rojas-García, Monserrat Sordo, Libia Vega, Bezabet Quintanilla-Vega, Maria Solis-Heredia and Patricia Ostrosky-Wegman

    Version of Record online : 28 APR 2009, DOI: 10.1002/em.20492

  15. Some Anticancer Agents Act on Human Serum Paraoxonase-1 to Reduce Its Activity

    Chemical Biology & Drug Design

    Volume 88, Issue 2, August 2016, Pages: 188–196, Zuhal Alim and Şükrü Beydemir

    Version of Record online : 15 MAR 2016, DOI: 10.1111/cbdd.12746

  16. PON1 L55M polymorphism is not a predictor of coronary atherosclerosis either alone or in combination with Q192R polymorphism in an Italian population

    European Journal of Clinical Investigation

    Volume 32, Issue 1, January 2002, Pages: 9–15, M. Arca, D. Ombres, A. Montali, F. Campagna, E. Mangieri, G. Tanzilli, P. P. Campa, G. Ricci, R. Verna and G. Pannitteri

    Version of Record online : 25 JAN 2002, DOI: 10.1046/j.1365-2362.2002.00935.x

  17. Downregulation of human paraoxonase 1 (PON1) by organophosphate pesticides in HepG2 cells

    Environmental Toxicology

    Volume 32, Issue 2, February 2017, Pages: 490–500, Irma Martha Medina-Díaz, Néstor Ponce-Ruiz, Bryana Ramírez-Chávez, Aurora Elizabeth Rojas-García, Briscia S. Barrón-Vivanco, Guillermo Elizondo and Yael Y. Bernal-Hernández

    Version of Record online : 7 MAR 2016, DOI: 10.1002/tox.22253

  18. First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data

    Cell Biochemistry and Function

    Volume 29, Issue 2, March 2011, Pages: 156–163, Junko Fujihara, Toshihiro Yasuda, Yasuyuki Kawai, Norihiro Morikawa, Kenichiro Arakawa, Yoshiro Koda, Mikiko Soejima, Kaori Kimura-Kataoka and Haruo Takeshita

    Version of Record online : 2 FEB 2011, DOI: 10.1002/cbf.1721

  19. You have free access to this content
    Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus

    Arthritis & Rheumatism

    Volume 54, Issue 6, June 2006, Pages: 1928–1939, Laura M. Tripi, Susan Manzi, Qi Chen, Margaret Kenney, Penny Shaw, Amy Kao, Franklin Bontempo, Candace Kammerer and M. Ilyas Kamboh

    Version of Record online : 25 MAY 2006, DOI: 10.1002/art.21889

  20. You have free access to this content
    Genetic Variation in the Paraoxonase-3 (PON3) Gene is Associated with Serum PON1 Activity

    Annals of Human Genetics

    Volume 72, Issue 1, January 2008, Pages: 72–81, Dharambir K. Sanghera, Susan Manzi, Ryan L. Minster, Penny Shaw, Amy Kao, Franklin Bontempo and M. Ilyas Kamboh

    Version of Record online : 27 SEP 2007, DOI: 10.1111/j.1469-1809.2007.00400.x